| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.33 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |